Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02939274 |
Title | An Open Label, Phase II Trial of Continuous Low-Irradiance Photodynamic Therapy (CLIPT) Using Verteporfin (Visudyne) for the Treatment of Cutaneous Metastases of Breast Cancer |
Recruitment | Unknown status |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Rogers Sciences Inc. |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |